Microtubule-targeting and regulation of HIF-1
Microtubule-targeting and regulation of HIF-1
批准号:
7184914
负责人:
PARASKEVI GIANNAKAKOU
金额:
$28.09万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-04-01 至 2010-03-31
关键词:
MCF7 cellangiogenesisdynein ATPaseepothilonestradiolgene induction /repressiongenetic regulationgenetic translationhypoxia inducible factor 1immunoprecipitationmessenger RNAmicrotubulesmolecular oncologyneoplasm /cancer blood supplynucleic acid sequencepaclitaxelprotein localizationprotein transportrenal cell carcinomatransmission electron microscopyvinca alkaloids
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): 2-Methoxyestradiol (2ME2) is a naturally occurring derivative of estradiol currently in Phase l/ll clinical trials as an inhibitor of tumor angiogenesis. We have recently reported that 2ME2 potently inhibits the protein levels and transcriptional activity of the pro-angiogenic and pro-survival transcription factor HIF-1 alpha. Moreover, we showed that HIF-1 alpha inhibition occurs downstream of disruption of the microtubule cytoskeleton by 2ME2. These data provide the first mechanistic link between targeting of the microtubule cytoskeleton and inhibition of tumor angiogenesis. However, the cellular signals that lead from microtubule disruption to HIF-1 alpha inhibition remain unknown. With this proposal, we seek to build upon our previous work in order to investigate in detail the molecular mechanism(s) that lead from microtubule disruption to inhibition of tumor angiogenesis and survival. Our hypothesis is that 2ME2 has a bivalent effect on the chemomechanics of microtubule-dependent HIF-1 alpha activation. By disrupting cellular microtubules, 2ME2 inhibits HIF-1 alpha nuclear translocation and HIF-1 alpha translation, thus, resulting in inhibition of HIF-1 alpha activity. To elucidate the mechanism by which microtubule disruption regulates HIF-1 alpha activity we plan to: I) Elucidate the mechanism by which 2ME2 inhibits HIF-1 nuclear translocation, II) Define the mechanism by which 2ME2 inhibits HIF-1 alpha translation and III) Investigate whether abrogation of microtubule-dependent regulation of HIF-1 alpha in VHL-mutant renal cell carcinomas (RCCs), results in 2ME2 resistance. We will also expand these observations to additional classes of microtubule-targeting drugs, such as the taxanes, the epothilones and the vinca alkaloids. With this proposal we are seeking to build on our previous work and advance our understanding of the basic mechanisms governing the microtubule-dependent regulation of the HIF pathway, as well as their impact on tumor survival and chemosensitivity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developmental Research Program (DRP)
-
批准号:10227734
-
项目类别:
-
资助金额:$9.74万
-
财政年份:2017
-
负责人:PARASKEVI GIANNAKAKOU
-
依托单位:
Mechanistic Insights Underlying ERG-induced Taxane Resistance in Castration-Resis
-
批准号:9440347
-
项目类别:
-
资助金额:$42.89万
-
财政年份:2014
-
负责人:PARASKEVI GIANNAKAKOU
-
依托单位:
Microtubule-Regulated RNA Translation: Implications for Taxane Chemotherapy
-
批准号:8655336
-
项目类别:
-
资助金额:$36.11万
-
财政年份:2014
-
负责人:PARASKEVI GIANNAKAKOU
-
依托单位:
Mechanistic Insights Underlying ERG-induced Taxane Resistance in Castration-Resis
-
批准号:8704646
-
项目类别:
-
资助金额:$42.89万
-
财政年份:2014
-
负责人:PARASKEVI GIANNAKAKOU
-
依托单位:
Mechanistic Insights Underlying ERG-induced Taxane Resistance in Castration-Resis
-
批准号:8837583
-
项目类别:
-
资助金额:$42.89万
-
财政年份:2014
-
负责人:PARASKEVI GIANNAKAKOU
-
依托单位:
Mechanistic Insights Underlying ERG-induced Taxane Resistance in Castration-Resis
-
批准号:9017961
-
项目类别:
-
资助金额:$42.89万
-
财政年份:2014
-
负责人:PARASKEVI GIANNAKAKOU
-
依托单位:
Microtubule-Regulated RNA Translation: Implications for Taxane Chemotherapy
-
批准号:8842107
-
项目类别:
-
资助金额:$35.82万
-
财政年份:2014
-
负责人:PARASKEVI GIANNAKAKOU
-
依托单位:
Microtubule dependent AR signaling predicts taxane sensitivity
-
批准号:8469008
-
项目类别:
-
资助金额:$31.97万
-
财政年份:2009
-
负责人:PARASKEVI GIANNAKAKOU
-
依托单位:
Microtubule dependent AR signaling predicts taxane sensitivity
-
批准号:8266465
-
项目类别:
-
资助金额:$34.02万
-
财政年份:2009
-
负责人:PARASKEVI GIANNAKAKOU
-
依托单位:
Microtubule dependent AR signaling predicts taxane sensitivity
-
批准号:7736273
-
项目类别:
-
资助金额:$35.07万
-
财政年份:2009
-
负责人:PARASKEVI GIANNAKAKOU
-
依托单位:
Microtubule dependent AR signaling predicts taxane sensitivity
-
批准号:8073086
-
项目类别:
-
资助金额:$34.02万
-
财政年份:2009
-
负责人:PARASKEVI GIANNAKAKOU
-
依托单位:
Targeting Microtubules and HDAC6 in NSCLC
-
批准号:7109525
-
项目类别:
-
资助金额:$21.63万
-
财政年份:2006
-
负责人:PARASKEVI GIANNAKAKOU
-
依托单位:
Microtubule-targeting and regulation of HIF-1
-
批准号:7595232
-
项目类别:
-
资助金额:$28.31万
-
财政年份:2005
-
负责人:PARASKEVI GIANNAKAKOU
-
依托单位:
Microtubule-targeting and regulation of HIF-1
-
批准号:7233248
-
项目类别:
-
资助金额:$28.31万
-
财政年份:2005
-
负责人:PARASKEVI GIANNAKAKOU
-
依托单位:
Microtubule-targeting and regulation of HIF-1
-
批准号:7390224
-
项目类别:
-
资助金额:$28.31万
-
财政年份:2005
-
负责人:PARASKEVI GIANNAKAKOU
-
依托单位:
Microtubule-targeting and regulation of HIF-1
-
批准号:7046865
-
项目类别:
-
资助金额:$29.16万
-
财政年份:2005
-
负责人:PARASKEVI GIANNAKAKOU
-
依托单位:
Antitubulin drugs: Mechanisms of action and resistance
-
批准号:7027635
-
项目类别:
-
资助金额:$28.35万
-
财政年份:2003
-
负责人:PARASKEVI GIANNAKAKOU
-
依托单位:
Antitubulin drugs: Mechanisms of action and resistance
-
批准号:6598337
-
项目类别:
-
资助金额:$27.06万
-
财政年份:2003
-
负责人:PARASKEVI GIANNAKAKOU
-
依托单位:
Antitubulin drugs: Mechanisms of action and resistance
-
批准号:7158489
-
项目类别:
-
资助金额:$29.2万
-
财政年份:2003
-
负责人:PARASKEVI GIANNAKAKOU
-
依托单位:
Antitubulin drugs: Mechanisms of action and resistance
-
批准号:6919883
-
项目类别:
-
资助金额:$27.06万
-
财政年份:2003
-
负责人:PARASKEVI GIANNAKAKOU
-
依托单位:
国内基金
海外基金
登录
查看更多内容
RGD-68Ga@AuNCs PET监测PRMT5通过VEGFA调节肺腺癌血管新生的功能及机制
-
批准号:82372007
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:谢文晖
-
依托单位:
PROCR信号通路介导的血管新生在卵巢组织移植中的作用及机制研究
-
批准号:82371726
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:李文
-
依托单位:
RNA编辑型IGFBP7在肿瘤细胞与肿瘤血管微环境中的调控作用及机制研究
-
批准号:32070790
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:徐小燕
-
依托单位:
ROBO4对视网膜血管生成(angiogenesis)的调控及其分子机制
-
批准号:81200692
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:陈凌
-
依托单位:
基于新生血管显像研究MSC治疗缺血性脑血管病的转化医学关键问题
-
批准号:81171370
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:朱朝晖
-
依托单位:
探索VASH2转录激活对肝细胞癌血管生成和上皮间质转化的作用及机制
-
批准号:81172267
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:高文涛
-
依托单位:
解析miR-566调控VHL/β-catenin信号通路影响人脑胶质瘤血管新生的分子机制
-
批准号:81101916
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:周旋
-
依托单位:
脂肪组织来源干细胞促进颗粒脂肪游离移植后再血管化机制的实验研究
-
批准号:81171834
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:鲁峰
-
依托单位:
99mTc-3PRGD2 SPECT显像用于评价肺癌抗新生血管药物疗效的动物研究及肺癌诊断临床研究
-
批准号:81171369
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2011
-
负责人:李方
-
依托单位:
核素靶向示踪肿瘤新生血管作用位点研究
-
批准号:81071183
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2010
-
负责人:王荣福
-
依托单位: